Debra Sarasohn

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

R.S. Suidan, Pedro T. Ramírez, Debra Sarasohn et al. · Gynecologic Oncology · 2014 · 225 citations · Full text

Medicine, Oncology, Surgery +17

Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies

Owen A. O’Connor, Steven M. Horwitz, Paul A. Hamlin et al. · Journal of Clinical Oncology · 2009 · 183 citations

Medicine, Pharmacology, Pharmacotherapy +17

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer

R.S. Suidan, Pedro T. Ramírez, Debra Sarasohn et al. · Gynecologic Oncology · 2017 · 143 citations · Full text

Medicine, Oncology, Surgery +16

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia

Gerald A. Soff, Yimei Miao, Gemma Bendheim et al. · Journal of Clinical Oncology · 2019 · 130 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study

Simon Mantha, Eva Laube, Yimei Miao et al. · Journal of Thrombosis and Thrombolysis · 2016 · 102 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17